Pfizer Recalls All of Its Sickle Cell Disease Treatment Over Safety Concerns

Key TakeawaysPfizer is withdrawing all of its sickle cell disease drug, Oxbryta, worldwide because of safety concerns.The drug maker said the benefits of Oxbryta no longer outweigh the risks.The company's data indicated patients could suffer from severe pain and even death. Pfizer (PFE) shares declined Thursday after the drug maker recalled all lots of its sickle cell disease medicine worldwide because of concerns it could lead to severe pain and possibly death in patients.  The company announced it was vo ...